These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 16000453)

  • 21. Appearance of aac(6')-Ib-cr gene among extended-spectrum beta-lactamase-producing Enterobacteriaceae in a French hospital.
    Fihman V; Lartigue MF; Jacquier H; Meunier F; Schnepf N; Raskine L; Riahi J; Sanson-le Pors MJ; Berçot B
    J Infect; 2008 Jun; 56(6):454-9. PubMed ID: 18440645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community setting.
    Arpin C; Quentin C; Grobost F; Cambau E; Robert J; Dubois V; Coulange L; André C;
    J Antimicrob Chemother; 2009 Jun; 63(6):1205-14. PubMed ID: 19329798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extended spectrum beta-lactamase producing Enterobacteriaceae in Lebanese ICU patients: epidemiology and patterns of resistance.
    Daoud Z; Moubareck C; Hakime N; Doucet-Populaire F
    J Gen Appl Microbiol; 2006 Jun; 52(3):169-78. PubMed ID: 16960333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
    Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
    J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of extended-spectrum beta-lactamases.
    Rodríguez-Baño J; Pascual A
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):671-83. PubMed ID: 18847405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and characterization of extended spectrum β-lactamases in Klebsiella-Enterobacter-Serratia group bacteria, in Algeria.
    Nedjai S; Barguigua A; Djahmi N; Jamali L; Zerouali K; Dekhil M; Timinouni M
    Med Mal Infect; 2012 Jan; 42(1):20-9. PubMed ID: 22056377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients.
    Ben-Ami R; Rodríguez-Baño J; Arslan H; Pitout JD; Quentin C; Calbo ES; Azap OK; Arpin C; Pascual A; Livermore DM; Garau J; Carmeli Y
    Clin Infect Dis; 2009 Sep; 49(5):682-90. PubMed ID: 19622043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissemination of extended-spectrum beta-lactamase-producing Enterobacteriaceae in intensive care units of a medical center in Taiwan.
    Wu TL; Chia JH; Su LH; Chu C; Kuo AJ; Chiu CH
    Microb Drug Resist; 2006; 12(3):203-9. PubMed ID: 17002548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nosocomial outbreak due to extended-spectrum-beta-lactamase- producing Enterobacter cloacae in a cardiothoracic intensive care unit.
    Manzur A; Tubau F; Pujol M; Calatayud L; Dominguez MA; Peña C; Sora M; Gudiol F; Ariza J
    J Clin Microbiol; 2007 Aug; 45(8):2365-9. PubMed ID: 17581932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characterization and antimicrobial susceptibility of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae isolates at a tertiary-care centre in Monterrey, Mexico.
    Garza-González E; Mendoza Ibarra SI; Llaca-Díaz JM; Gonzalez GM
    J Med Microbiol; 2011 Jan; 60(Pt 1):84-90. PubMed ID: 20930052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of CTX-M-15 beta-lactamases in Enterobacteriaceae causing hospital- and community-acquired urinary tract infections as early as 2004, in Dar es Salaam, Tanzania.
    Manyahi J; Moyo SJ; Tellevik MG; Ndugulile F; Urassa W; Blomberg B; Langeland N
    BMC Infect Dis; 2017 Apr; 17(1):282. PubMed ID: 28415986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland.
    Lartigue MF; Zinsius C; Wenger A; Bille J; Poirel L; Nordmann P
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2855-60. PubMed ID: 17470647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and molecular analysis of extended-spectrum {beta}-lactamase-producing enterobacteria in the community setting.
    Arpin C; Dubois V; Maugein J; Jullin J; Dutilh B; Brochet JP; Larribet G; Fischer I; Quentin C
    J Clin Microbiol; 2005 Oct; 43(10):5048-54. PubMed ID: 16207960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of CHROMagar CTX, a novel medium for isolating CTX-M-ESBL-positive Enterobacteriaceae while inhibiting AmpC-producing strains.
    Randall LP; Kirchner M; Teale CJ; Coldham NG; Liebana E; Clifton-Hadley F
    J Antimicrob Chemother; 2009 Feb; 63(2):302-8. PubMed ID: 19043079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
    Baroud M; Dandache I; Araj GF; Wakim R; Kanj S; Kanafani Z; Khairallah M; Sabra A; Shehab M; Dbaibo G; Matar GM
    Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular epidemiology and antimicrobial resistance pattern of extended-spectrum-β-lactamase-producing Enterobacteriaceae in Glasgow, Scotland.
    Khanna N; Boyes J; Lansdell PM; Hamouda A; Amyes SG
    J Antimicrob Chemother; 2012 Mar; 67(3):573-7. PubMed ID: 22169188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae, Serratia marcescens and Enterobacter cloacae.
    Ku YH; Chuang YC; Yu WL
    J Microbiol Immunol Infect; 2008 Aug; 41(4):332-6. PubMed ID: 18787741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extended-spectrum β-lactamases and plasmid-mediated quinolone resistance in enterobacterial clinical isolates in the paediatric hospital of Uruguay.
    García-Fulgueiras V; Bado I; Mota MI; Robino L; Cordeiro NF; Varela A; Algorta G; Gutkind G; Ayala JA; Vignoli R
    J Antimicrob Chemother; 2011 Aug; 66(8):1725-9. PubMed ID: 21685201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility testing accuracy of a CTX-M-type extended-spectrum beta-lactamase organism-producing population of Enterobacteriaceae: intermethod analysis for 9 beta-lactams.
    Pottumarthy S; Yu Y; Sader HS; Jones RN; Chen M
    Diagn Microbiol Infect Dis; 2005 Oct; 53(2):131-41. PubMed ID: 15939566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection.
    Stürenburg E; Sobottka I; Noor D; Laufs R; Mack D
    J Antimicrob Chemother; 2004 Jul; 54(1):134-8. PubMed ID: 15150168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.